[Cite as http://purl.org/au-research/grants/nhmrc/1070880]
Dr Melissa Cantley
Brief description Multiple myeloma (MM) is an incurable hematological malignancy with 1,400 people diagnosed each year. Severe bone loss occurs in up to 90% of these patientssignificantly impacting on quality of life resulting in severe bone pain and bone lesions that fail to heal. This project proposes that a novel histone deacetylase inhibitor could provide an appropriate therapeutic strategy that inhibits tumor growth and prevents bone loss whilst also promoting bone repair.
Funding Amount $AUD 356,899.46
Funding Scheme Early Career Fellowships
Peter Doherty Biomedical ECF